HKU Scholars Hub: Browsing DSpace

Browsing by Author Rushing, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 8 of 8

	Title	Author(s)	Issue Date
	A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer Journal:The Oncologist	Vlahovic, G Meadows, KL Hatch, AJ Jia, J Nixon, A Uronis, HE Morse, MA Selim, MA Crawford, J Riedel, R Zafar, SY Howard, LA O'Neill, M Meadows, JJ Haley, ST Arrowood, CC Rushing, C Pang, H Hurwitz, HI	2018
	Biomarker modulation in patients (pts) receiving TRC105 (T) and bevacizumab (B) in a phase Ib clinical trial Proceeding/Conference:Journal of Clinical Oncology	Liu, Y Clarke, J Starr, MD Brady, JC Pang, HMH Rushing, C Alvarez, D Adams, BJ Theuer, CP Hurwitz, H Nixon, AB	2014
	Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus Journal:Molecular Cancer Therapeutics	Liu, Y Starr, M Brady, J Rushing, C Bulusu, A Pang, HMH Honeycutt, W Amara, A Altomare, I Uronis, H	2015
	Correlation of Src activation with response to dasatinib, capecitabine, oxaliplatin, and bevacizumab in advanced solid tumors Proceeding/Conference:Journal of Clinical Oncology	Strickler, JH McCall, S Nixon, AB Pang, HMH Rushing, C Arrowood, C Haley, S Meadows, K Hurwitz, H	2013
	Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing Journal:Clinical Cancer Research	Jia, J Dellinger, A Weiss, E Bulusu, A Rushing, C Li, H Howard, L Kaplan, N Pang, HMH Hurwitz, H	2015
	A leave-one-out cross-validation SAS macro for the identification of markers associated with survival Journal:Computers in Biology and Medicine	Rushing, C Bulusu, A Hurwitz, H Nixon, A Pang, HMH	2015
	Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105 Journal:Molecular Cancer Therapeutics	Liu, Y Starr, MD Brady, JC Rushing, C Pang, H Adams, B Alvarez, D Theuer, CP Hurwitz, HI Nixon, AB	2018
	Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer Journal:Investigational New Drugs	Strickler, JH McCall, S Nixon, AB Brady, JC Pang, H Rushing, C Cohn, A Starodub, A Arrowood, C Haley, S Meadows, KL Morse, MA Uronis, HE Blobe, GC Hsu, SD Zafar, SY Hurwitz, HI	2014

Showing results 1 to 8 of 8